Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. Despite significant volatility, ...

Recursion struggles with losses and high cash burn despite a $500M IPO. See why RXRX stock remains a "Hold" amid funding ...

“Time Off for Clinical Trials," launched on Nov. 20, sees six of BioNJ’s biggest members—Amicus Therapeutics, Bristol Myers ...

Beyond Business School, a company founded by serial entrepreneurs Andra Ghibuțiu and Grégoire Vigroux, announces the final ...

Australia’s medicines watchdog says parents should immediately stop giving a popular medicine to kids under the age of six, ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...

Paul Weiss is picking up a pair of patent litigators from Weil Gotshal & Manges as the New York firm’s hiring spree moves to ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today released its 2025 financial calendar: ...

A study using a Korean database found that COVID-19 infection raised long-term risks for various autoimmune and ...

In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price ...

In November Brisbane Times revealed the extent of the city’s illegal tobacco trade. More than 5.2 million cigarettes and 1.2 ...

Australia’s medicines watchdog has now issued an urgent safety alert, advising that Phenergan not be given to children aged ...